FibroScan®

Fibroscan is a non-invasive and quantitative examination device for the liver, represented by Mediplast through Echosens. The device enables simultaneous examination for fibrosis and steatosis. It is available as an ultra-mobile model for quick and flexible screening outside the clinic.

Specialized diagnostic device for quantifying liver fibrosis severity using advanced transient elastography. Provides accurate measurement of liver tissue elasticity to assess disease progression and treatment response in chronic liver disease patients.

Specialized ultrasound platform measuring tissue stiffness and elasticity. Supports liver fibrosis and tissue characterization assessment.

Non-invasive diagnostic system designed for hepatic fibrosis assessment and screening. Enables early detection and monitoring of liver disease progression without tissue biopsy.

Ultrasound-based diagnostic system for detecting and measuring hepatic steatosis (fatty liver disease). Uses acoustic attenuation imaging to quantify fat content in liver tissue for non-invasive assessment of liver health status.

Portable liver elastography ultrasound diagnostic system equipped with a phased array probe. Offers both B-mode and transient elastography modes with a liver stiffness measurement range of 1.5 to 75 kPa, supporting model-level evaluation and configuration discussion.

A next-generation standardized quality control visual detection system for liver elastography using ultrasound technology. The portable diagnostic system enables liver fibrosis assessment with clinical-grade precision. It has been awarded the 2022 inaugural BOCHK Science and Technology Innovation Prize and received a 2021 Silver medal at the Special Edition Inventions Geneva Evaluation Days.

A portable fatty liver diagnostic device designed for convenient home and laboratory use. The device enables non-invasive assessment of hepatic steatosis with laboratory-grade precision. It is a 2026 CES Innovation Award Winner.

An AI-powered diagnostic system utilizing deep learning algorithms to enable non-invasive detection and assessment of hepatic fibrosis. The system analyzes imaging data to provide quantitative fibrosis staging without requiring tissue biopsy.

A diagnostic system developed using deep learning methods guided by physical theory principles to enable non-invasive detection of liver fibrosis. The system assists doctors and researchers in analyzing liver biopsy tissue samples.

Specialized ultrasound equipment for tissue elasticity assessment and fibrosis evaluation. These systems enable non-invasive evaluation of tissue stiffness for disease characterization.

An AI-powered wireless ultrasound device for liver health screening that integrates real-time B-mode ultrasound imaging with Transient Elastography (TE) in a single handheld probe. The device uses four purpose-built AI models for quality control, precision measurement, intelligent adaptation, and accurate quantification. It requires only 4 measurements compared to 10 for conventional systems, achieving 90% accuracy and more than doubling examination efficiency. Liverscan is designed for hepatology, gastroenterology, and general practice settings, enabling bedside liver assessment in approximately 1 minute.